thalidomide has been researched along with AIDS, Simian in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Fabio, S | 2 |
| Trabattoni, D | 2 |
| Geraci, A | 2 |
| Ruzzante, S | 2 |
| Panzini, G | 2 |
| Fusi, ML | 2 |
| Chiarotti, F | 2 |
| Corrias, F | 2 |
| Belli, R | 2 |
| Verani, P | 2 |
| Dalgleish, A | 2 |
| Clerici, M | 2 |
| Titti, F | 2 |
2 other studies available for thalidomide and AIDS, Simian
| Article | Year |
|---|---|
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys.
Topics: Administration, Oral; Animals; CD28 Antigens; HIV Infections; Humans; Immunosuppressive Agents; Maca | 1998 |
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeys.
Topics: Administration, Oral; Animals; Anti-HIV Agents; CD28 Antigens; CD4 Lymphocyte Count; CD8-Positive T- | 2000 |